The global high throughput screening (HTS) market is projected to grow at a CAGR of 7%-9% during 2020 to 2025. The growth of high throughput screening (HTS) market is driven by growing adoption of open innovation models in pharmaceutical and biotechnology companies, increasing R&D spending, and the availability of government funding and venture capital investments.
Some of the Key Questions answered in this exclusive report are:
Q.1 What are some of the
most promising potential, high-growth opportunities for the global high
throughput screening (HTS) market product & service (reagents & assay
kits, instruments, consumables & accessories, software, and services),
technology (cell-based assays (2D cell culture, 3D cell culture (scaffold-based
technology and scaffold-free technology), perfusion cell culture, and reporter
based assays), lab-on-a-chip, ultra-high-throughput screening, bioinformatics,
and label-free technology), application (drug discovery (target identification
and validation, primary and secondary screening, and toxicology assessment),
chemical biology programs, cell- & organ-based screening, biochemical
screening, biological active compound screening, genomics, proteomics, and
compound profiling), detection method (mass spectrometry (MS), chromatography,
calorimetry, x-ray diffraction, and other detection methods), end user
(pharmaceutical and biotechnology companies, academic and government institutes,
contract research organizations (CRO), and other end users) and region (North America, Europe, Asia
Pacific, and Rest of the World)?
Q.2 Which segments will
grow at a faster pace and why?
Q.3 What are the
business risks and threats to the high throughput screening (HTS) market?
Q.4 What are some
changing demands of customers in the high throughput screening (HTS) market?
Q.5 What are the new
developments in the high throughput screening (HTS) market? Which companies are
leading these developments?
Q.6 What strategic
initiatives are being implemented by key players for business growth?
Q.7 What are some of the
competitive products and processes in this high throughput screening (HTS) area
and how big of a threat do they pose for loss of market share via product
substitution?
Q.8 What M&A activity has occurred in the last 5 years in this high throughput screening (HTS) market?
Download Brochure of this report by
clicking on https://www.lucintel.com/high-throughput-screening-market.aspx
Market Segmentation:
Based on product &
service, the high throughput screening (HTS) market is segmented into reagents
& assay kits, instruments, consumables & accessories, software, and services.
The reagents & assay kits segment accounted for the largest share of the
market in 2020 and is expected to register the highest CAGR during the forecast
period, due to primarily be attributed to factors, such as the large number of
reagents and assay kits used in HTS techniques, rising prevalence of a number
of diseases, increasing pharmaceutical R&D, and increased government
funding for life science research.
North America will
remain the largest region over the forecast period due to large spending on
pharmaceutical R&D, the growing adoption of HTS, and availability of
government funding in this region.
Key Players in the high
throughput screening (HTS) market are Agilent Technologies, Danaher,
Thermofisher Scientific, PerkinElmer, Tecan Group, Merck Millipore, Bio-Rad
Laboratories, Hamilton Company, Axxam, and Aurora Biomed.
Request Sample Pages by clicking on
https://www.lucintel.com/high-throughput-screening-market.aspx
The report helps stakeholders understand the
pulse of the market and provides them with information on key drivers,
restraints, challenges, and opportunities for market growth. It would also help
to understand the competitors better and gain more insights to improve their
position in the business.
To read more about this market please click on
https://www.lucintel.com/high-throughput-screening-market.aspx
About
Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Brandon
Fitzgerald
Lucintel
Dallas,
Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Healthcare
IT Market:
For more details click here https://www.lucintel.com/healthcare-it-market.aspx
Medical
Holography Market:
For more details click here https://www.lucintel.com/medical-holography-market.aspx
Minimally Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx
Endoscopy Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx
Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx
Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx
Industrial
Microbiology Market:
For more details click here https://www.lucintel.com/opportunities-in-the-industrial-microbiologycolonopt-size,-trends-and-growth-analysis.aspx
Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx
Tumor
Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx
Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx
No comments:
Post a Comment